Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 194

1.

Modeling human neurological disorders with induced pluripotent stem cells.

Imaizumi Y, Okano H.

J Neurochem. 2014 May;129(3):388-99. doi: 10.1111/jnc.12625. Epub 2013 Dec 15. Review.

PMID:
24286589
[PubMed - indexed for MEDLINE]
2.

Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.

Chen LW, Kuang F, Wei LC, Ding YX, Yung KK, Chan YS.

CNS Neurol Disord Drug Targets. 2011 Jun;10(4):449-58. Review.

PMID:
21495962
[PubMed - indexed for MEDLINE]
3.

Induced pluripotent stem cells and neurodegenerative diseases.

Chen C, Xiao SF.

Neurosci Bull. 2011 Apr;27(2):107-14. doi: 10.1007/s12264-011-1147-9. Review.

PMID:
21441972
[PubMed - indexed for MEDLINE]
4.

Induced pluripotent stem cell research: a revolutionary approach to face the challenges in drug screening.

Song M, Paul S, Lim H, Dayem AA, Cho SG.

Arch Pharm Res. 2012 Feb;35(2):245-60. doi: 10.1007/s12272-012-0205-9. Epub 2012 Feb 28. Review.

PMID:
22370779
[PubMed - indexed for MEDLINE]
5.

Induced pluripotent stem cells in the study of neurological diseases.

Saporta MA, Grskovic M, Dimos JT.

Stem Cell Res Ther. 2011 Sep 21;2(5):37. doi: 10.1186/scrt78. Review.

PMID:
21936964
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

iPS cell technologies: significance and applications to CNS regeneration and disease.

Okano H, Yamanaka S.

Mol Brain. 2014 Mar 31;7:22. doi: 10.1186/1756-6606-7-22.

PMID:
24685317
[PubMed - in process]
Free PMC Article
7.

Patient-specific induced pluripotent stem cells in neurological disease modeling: the importance of nonhuman primate models.

Qiu Z, Farnsworth SL, Mishra A, Hornsby PJ.

Stem Cells Cloning. 2013 Jul 3;6:19-29. doi: 10.2147/SCCAA.S34798. Review.

PMID:
24426786
[PubMed]
Free PMC Article
8.

Induced pluripotent stem cells as a model for accelerated patient- and disease-specific drug discovery.

Gunaseeli I, Doss MX, Antzelevitch C, Hescheler J, Sachinidis A.

Curr Med Chem. 2010;17(8):759-66. Review.

PMID:
20088756
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Induced pluripotent stem (iPS) cells as in vitro models of human neurogenetic disorders.

Chamberlain SJ, Li XJ, Lalande M.

Neurogenetics. 2008 Oct;9(4):227-35. doi: 10.1007/s10048-008-0147-z. Epub 2008 Sep 13. Review.

PMID:
18791750
[PubMed - indexed for MEDLINE]
10.

Stem cell applications in regenerative medicine for neurological disorders.

Liu SP, Fu RH, Huang SJ, Huang YC, Chen SY, Chang CH, Liu CH, Tsai CH, Shyu WC, Lin SZ.

Cell Transplant. 2013;22(4):631-7. doi: 10.3727/096368912X655145. Epub 2012 Oct 31. Review.

PMID:
23127757
[PubMed - indexed for MEDLINE]
11.

Accelerating progress in induced pluripotent stem cell research for neurological diseases.

Ito D, Okano H, Suzuki N.

Ann Neurol. 2012 Aug;72(2):167-74. doi: 10.1002/ana.23596. Review.

PMID:
22926850
[PubMed - indexed for MEDLINE]
12.

Induced pluripotent stem cells and neurological disease models.

Cai S, Chan YS, Shum DK.

Sheng Li Xue Bao. 2014 Feb 25;66(1):55-66.

PMID:
24553870
[PubMed - in process]
Free Article
13.

Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling.

Iglesias-García O, Pelacho B, Prósper F.

J Mol Cell Cardiol. 2013 Sep;62:43-50. doi: 10.1016/j.yjmcc.2013.04.022. Epub 2013 Apr 30. Review.

PMID:
23643470
[PubMed - indexed for MEDLINE]
14.

[A challenge towards the clinical application of induced pluripotent stem cell technology for the treatment of Parkinson's disease].

Morizane A, Takahashi J.

Brain Nerve. 2012 Jan;64(1):29-37. Review. Japanese.

PMID:
22223499
[PubMed - indexed for MEDLINE]
15.

Induced pluripotent stem cells: a new technology to study human diseases.

Vitale AM, Wolvetang E, Mackay-Sim A.

Int J Biochem Cell Biol. 2011 Jun;43(6):843-6. doi: 10.1016/j.biocel.2011.03.013. Epub 2011 Mar 31. Review.

PMID:
21458591
[PubMed - indexed for MEDLINE]
16.

Human-induced pluripotent stem cells: in quest of clinical applications.

Madonna R.

Mol Biotechnol. 2012 Oct;52(2):193-203. Review.

PMID:
22302314
[PubMed - indexed for MEDLINE]
17.

Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes.

Liu H, Ye Z, Kim Y, Sharkis S, Jang YY.

Hepatology. 2010 May;51(5):1810-9. doi: 10.1002/hep.23626.

PMID:
20432258
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Genetically-modified human pluripotent stem cells: new hopes for the understanding and the treatment of neurological diseases?

Nedelec S, Onteniente B, Peschanski M, Martinat C.

Curr Gene Ther. 2013 Apr;13(2):111-9. Review.

PMID:
23444870
[PubMed - indexed for MEDLINE]
19.

The first reported generation of human induced pluripotent stem cells (iPS cells) and iPS cell-derived cardiomyocytes in the Netherlands.

Freund C, Davis RP, Gkatzis K, Ward-van Oostwaard D, Mummery CL.

Neth Heart J. 2010 Jan;18(1):51-4.

PMID:
20111645
[PubMed]
Free PMC Article
20.

The iPS technique provides hope for Parkinson's disease treatment.

Xu L, Tan YY, Ding JQ, Chen SD.

Stem Cell Rev. 2010 Sep;6(3):398-404. doi: 10.1007/s12015-010-9145-2. Review.

PMID:
20352528
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk